CD160 and colorectal carcinoma: In this study, we investigated gene expression levels of various inhibitory ICs including PD-1, TIM-3, LAG-3, VISTA, CTLA-4, TIGIT, CD160, CD244, and KLRG1 in the tumor tissue of CRC patients.